ID

28039

Descrição

Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Screening/Enrollment

Palavras-chave

Versões (6)
  1. 25/08/2017 25/08/2017 -
  2. 25/08/2017 25/08/2017 -
  3. 25/08/2017 25/08/2017 -
  4. 13/10/2017 13/10/2017 -
  5. 23/10/2017 23/10/2017 -
  6. 12/12/2017 12/12/2017 -
Titular dos direitos

GlaxoSmithKline

Transferido a

12 de dezembro de 2017

DOI

Para um pedido faça login.

Licença

Creative Commons BY-NC 3.0
Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Voltar para os comentários do modelo
Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Screening/Enrollment GSK study Chronic Coronary Heart Disease NCT00799903

Inglês

Screening/Enrollment GSK study Chronic CHD NCT00799903

1 Formulários  
Screening
Descrição

Screening

1. Subject initials
Descrição

This item is hidden to all users and will be autopopulated by the system as "---"

Tipo de dados

text

Alias
UMLS CUI [1]
C2986440
2. Date of birth
Descrição

Will be automatically mapped to demography form

Tipo de dados

date

Alias
UMLS CUI [1]
C0421451
3. eGFR value used for screening
Descrição

eGFR

Tipo de dados

integer

Alias
UMLS CUI [1]
C3811844
4. Was this subject a screen failure?
Descrição

If Yes, check all that apply. If you are not collecting data on screen failures then the Screen Failure question cannot be removed from the SCREEN form, although the list of reasons can be edited. Subject Number is optional. If not needed, remove control and from the group control.

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1710476
Reason for screen failure
Descrição

Reason for screen failure

[F01] Did not meet inclusion/exclusion criteria
Descrição

Inclusion exclusion criteria

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C0680251
[F10] Subject withdrew consent prior to randomisation
Descrição

Withdrawal of consent

Tipo de dados

boolean

[F06] Study closed/terminated prior to randomisation
Descrição

Study closed/ terminated

Tipo de dados

boolean

Alias
UMLS CUI [1]
C2348570
[F07] Lost to follow up prior to randomisation
Descrição

Lost to follow up

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1302313
If subject did not meet inclusion/exclusion criteria, specify:
Descrição

If subject did not meet inclusion/exclusion criteria, specify:

[I02] Inclusion Criteria 2: Male or female at least 18 years old at screening and females postmenopausal or using highly effective method to avoid pregnancy
Descrição

Inclusion Criteria sex pregnancy

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0032961
[I03] Inclusion Criteria 3: Current treatment with statin therapy unless contraindicated
Descrição

Inclusion Criteria statin therapy

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0360714
[I04] Inclusion Criteria 4: Chronic CHD documented
Descrição

Inclusion Criteria Chronic CHD

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0010068
[I05] Inclusion Criteria 5: At least one additional predictor of CV risk
Descrição

Inclusion Criteria additional predictors of CV risk

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0850624
[E01] Exclusion Criteria 1: Planned coronary revascularization (PCI or CABG) or any other major surgical procedure
Descrição

Exclusion Criteria Planned coronary PCI or CABG

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0085532
UMLS CUI [1,2]
C0010055
UMLS CUI [1,3]
C1532338
[E02] Exclusion Criteria 2: Current liver disease, known hepatic or biliary abnormalities evidence of abnormal liver function tests
Descrição

Exclusion Criteria abnormal liver function

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0086565
[E03] Exclusion Criteria 3: Severe renal impairment or history of nephrectomy or kidney transplant
Descrição

Exclusion Criteria renal impairment

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1565489
[E04] Exclusion Criteria 4: Current severe heart failure
Descrição

Exclusion Criteria heart failure

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0018801
[E05] Exclusion Criteria 5: Poorly controlled hypertension despite lifestyle modifications and pharmacotherapy
Descrição

Exclusion Criteria hypertension

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0020538
[E06] Exclusion Criteria 6: Any life-threatening condition with life expectancy less than 2 years
Descrição

Exclusion Criteria life expectancy less than 2 years

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0023671
[E07] Exclusion Criteria 7: Severe asthma that is poorly controlled on pharmacotherapy
Descrição

Exclusion Criteria asthma

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0680251
UMLS CUI [1,2]
C0155877
[E08] Exclusion Criteria 8: Positive pregnancy test or is known to be pregnant or lactating
Descrição

Exclusion Criteria pregnancy

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0680251
UMLS CUI [1,2]
C0032961
[E09] Exclusion Criteria 9: History of anaphylaxis, anaphylactoid reactions severe allergic responses
Descrição

Exclusion Criteria allergy

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0020517
[E10] Exclusion Criteria 10: Alcohol or drug abuse within the past 6 months, or current mental condition which may affect study compliance
Descrição

Exclusion Criteria Alcohol or drug abuse

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0038586
[E11] Exclusion Criteria 11: Current or planned chronic administration of strong oral or injectable CYP3A4 inhibitors
Descrição

Exclusion Criteria CYP3A4 inhibitors

Tipo de dados

boolean

Alias
UMLS CUI [1]
C3830624
[E12] Exclusion Criteria 12: Subjects with both parents of Japanese, Chinese, or Korean ancestry with Lp-PLA2 activity less or eq 20 nmol/min/mL
Descrição

Exclusion Criteria Lp-PLA2 activity

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0031671
[E13] Exclusion Criteria 13: Previous exposure to darapladib (SB-480848)
Descrição

Exclusion Criteria exposure to darapladib

Tipo de dados

boolean

Alias
UMLS CUI [1]
C2348075
[E14] Exclusion Criteria 14: Use of another investigational product within 30 days or 5 half-lives preceding the first dose of darapladib or matching placebo
Descrição

Exclusion Criteria Use of other IP

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0304229
[E15] Exclusion Criteria 15: Currently in a study of an investigational device
Descrição

Exclusion Criteria study of investigational device

Tipo de dados

boolean

Alias
UMLS CUI [1]
C2346570
[E16] Exclusion Criteria 16: Any other reason the investigator deems the subject to be unsuitable for the study
Descrição

Exclusion Criteria other

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0680251
UMLS CUI [1,2]
C0205394
[E16] Exclusion Criteria 16, specify:
Descrição

Exclusion Criteria other specification

Tipo de dados

text

Alias
UMLS CUI [1,1]
C0680251
UMLS CUI [1,2]
C2348235
Voltar ao início da página

Similar models

Screening/Enrollment GSK study Chronic CHD NCT00799903

1 Formulários
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
Screening
Subject initials
Item
1. Subject initials
text
C2986440 (UMLS CUI [1])
Date of birth
Item
2. Date of birth
date
C0421451 (UMLS CUI [1])
eGFR
Item
3. eGFR value used for screening
integer
C3811844 (UMLS CUI [1])
screen failure
Item
4. Was this subject a screen failure?
boolean
C1710476 (UMLS CUI [1])
Item Group
Reason for screen failure
Inclusion exclusion criteria
Item
[F01] Did not meet inclusion/exclusion criteria
boolean
C1512693 (UMLS CUI [1,1])
C0680251 (UMLS CUI [1,2])
Withdrawal of consent
Item
[F10] Subject withdrew consent prior to randomisation
boolean
Study closed/ terminated
Item
[F06] Study closed/terminated prior to randomisation
boolean
C2348570 (UMLS CUI [1])
Lost to follow up
Item
[F07] Lost to follow up prior to randomisation
boolean
C1302313 (UMLS CUI [1])
Item Group
If subject did not meet inclusion/exclusion criteria, specify:
Inclusion Criteria sex pregnancy
Item
[I02] Inclusion Criteria 2: Male or female at least 18 years old at screening and females postmenopausal or using highly effective method to avoid pregnancy
boolean
C0032961 (UMLS CUI [1])
Inclusion Criteria statin therapy
Item
[I03] Inclusion Criteria 3: Current treatment with statin therapy unless contraindicated
boolean
C0360714 (UMLS CUI [1])
Inclusion Criteria Chronic CHD
Item
[I04] Inclusion Criteria 4: Chronic CHD documented
boolean
C0010068 (UMLS CUI [1])
Inclusion Criteria additional predictors of CV risk
Item
[I05] Inclusion Criteria 5: At least one additional predictor of CV risk
boolean
C0850624 (UMLS CUI [1])
Exclusion Criteria Planned coronary PCI or CABG
Item
[E01] Exclusion Criteria 1: Planned coronary revascularization (PCI or CABG) or any other major surgical procedure
boolean
C0085532 (UMLS CUI [1,1])
C0010055 (UMLS CUI [1,2])
C1532338 (UMLS CUI [1,3])
Exclusion Criteria abnormal liver function
Item
[E02] Exclusion Criteria 2: Current liver disease, known hepatic or biliary abnormalities evidence of abnormal liver function tests
boolean
C0086565 (UMLS CUI [1])
Exclusion Criteria renal impairment
Item
[E03] Exclusion Criteria 3: Severe renal impairment or history of nephrectomy or kidney transplant
boolean
C1565489 (UMLS CUI [1])
Exclusion Criteria heart failure
Item
[E04] Exclusion Criteria 4: Current severe heart failure
boolean
C0018801 (UMLS CUI [1])
Exclusion Criteria hypertension
Item
[E05] Exclusion Criteria 5: Poorly controlled hypertension despite lifestyle modifications and pharmacotherapy
boolean
C0020538 (UMLS CUI [1])
Exclusion Criteria life expectancy less than 2 years
Item
[E06] Exclusion Criteria 6: Any life-threatening condition with life expectancy less than 2 years
boolean
C0023671 (UMLS CUI [1])
Exclusion Criteria asthma
Item
[E07] Exclusion Criteria 7: Severe asthma that is poorly controlled on pharmacotherapy
boolean
C0680251 (UMLS CUI [1,1])
C0155877 (UMLS CUI [1,2])
Exclusion Criteria pregnancy
Item
[E08] Exclusion Criteria 8: Positive pregnancy test or is known to be pregnant or lactating
boolean
C0680251 (UMLS CUI [1,1])
C0032961 (UMLS CUI [1,2])
Exclusion Criteria allergy
Item
[E09] Exclusion Criteria 9: History of anaphylaxis, anaphylactoid reactions severe allergic responses
boolean
C0020517 (UMLS CUI [1])
Exclusion Criteria Alcohol or drug abuse
Item
[E10] Exclusion Criteria 10: Alcohol or drug abuse within the past 6 months, or current mental condition which may affect study compliance
boolean
C0038586 (UMLS CUI [1])
Exclusion Criteria CYP3A4 inhibitors
Item
[E11] Exclusion Criteria 11: Current or planned chronic administration of strong oral or injectable CYP3A4 inhibitors
boolean
C3830624 (UMLS CUI [1])
Exclusion Criteria Lp-PLA2 activity
Item
[E12] Exclusion Criteria 12: Subjects with both parents of Japanese, Chinese, or Korean ancestry with Lp-PLA2 activity less or eq 20 nmol/min/mL
boolean
C0031671 (UMLS CUI [1])
Exclusion Criteria exposure to darapladib
Item
[E13] Exclusion Criteria 13: Previous exposure to darapladib (SB-480848)
boolean
C2348075 (UMLS CUI [1])
Exclusion Criteria Use of other IP
Item
[E14] Exclusion Criteria 14: Use of another investigational product within 30 days or 5 half-lives preceding the first dose of darapladib or matching placebo
boolean
C0304229 (UMLS CUI [1])
Exclusion Criteria study of investigational device
Item
[E15] Exclusion Criteria 15: Currently in a study of an investigational device
boolean
C2346570 (UMLS CUI [1])
Exclusion Criteria other
Item
[E16] Exclusion Criteria 16: Any other reason the investigator deems the subject to be unsuitable for the study
boolean
C0680251 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
Exclusion Criteria other specification
Item
[E16] Exclusion Criteria 16, specify:
text
C0680251 (UMLS CUI [1,1])
C2348235 (UMLS CUI [1,2])
Voltar ao início da página 

Contacto

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial